汪春林, 张勇. 血管内皮生长因子基因多态性与恶性肿瘤的研究进展[J]. 中国肿瘤临床, 2012, 39(24): 2117-2120. DOI: 10.3969/j.issn.1000-8179.2012.24.033
引用本文: 汪春林, 张勇. 血管内皮生长因子基因多态性与恶性肿瘤的研究进展[J]. 中国肿瘤临床, 2012, 39(24): 2117-2120. DOI: 10.3969/j.issn.1000-8179.2012.24.033
Chunlin WANG, Yong ZHANG. Research Progress on VEGF Gene Polymorphism for Malignant Tumor[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(24): 2117-2120. DOI: 10.3969/j.issn.1000-8179.2012.24.033
Citation: Chunlin WANG, Yong ZHANG. Research Progress on VEGF Gene Polymorphism for Malignant Tumor[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(24): 2117-2120. DOI: 10.3969/j.issn.1000-8179.2012.24.033

血管内皮生长因子基因多态性与恶性肿瘤的研究进展

Research Progress on VEGF Gene Polymorphism for Malignant Tumor

  • 摘要: 血管内皮生长因子(vascular endothelial growth factor, VEGF)是目前活性和专属性最强的血管生成因子, 在正常组织和肿瘤组织中都发挥着强大的促血管生成作用。血管生成是恶性肿瘤发生、发展及转移的关键之一, 并且VEGF几乎都参与恶性肿瘤的发生及进展过程。现已有较多研究从VEGF的基因水平上探讨其与恶性肿瘤的发生、发展、转移以及预后的关系, 因此VEGF基因多态性(single nucleotide polymorphisms, SNP)与恶性肿瘤的相关研究已成为目前的研究热点。故本文将对VEGF基因多态性与恶性肿瘤关系的最新研究进展进行综述。

     

    Abstract: Vascular endothelial growth factor(VEGF) gene polymorphism is closely related to the occurrence, development, metastasis, and prognosis of malignant tumor.VEGF and malignant tumors are currently the focus of many research.This article reviews the function of research development in VEGF gene polymorphism for malignant tumor.

     

/

返回文章
返回